January 17th, 2024: Ratio Therapeutics Announces $50M Series B ...
Jan 17, 2024 · Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90Million Since 2021 Launch. BOSTON, January 17, 2024 – Ratio Therapeutics Inc. …
OFF
January 17th, 2024: Ratio Therapeutics Announces $50M Series B ...
6 days from now
Jan 17, 2024 · Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90Million Since 2021 Launch. BOSTON, January 17, 2024 – Ratio Therapeutics Inc. …
ratiotx.com
OFF
Media - Ratio Therapeutics
6 days from now
Oct 23, 2024 · Ratio Therapeutics raises $50M for tumor-targeting radiopharmaceuticals. Boston Business Journal | January 17th, 2024. The Boston company has secured the backing to …
ratiotx.com
OFF
Ratio Therapeutics Announces $50M Series B Financing To …
6 days from now
BOSTON, Jan. 17, 2024 /PRNewswire/ -- Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class …
prnewswire.com
OFF
Ratio Therapeutics Raises $50M For Tumor-targeting …
6 days from now
Jan 17, 2024 · The company also announced plans to move into its new, 19,000-square-foot facility in Boston's Seaport District, which it officially opened in May 2023. Hoppin said the …
bizjournals.com
OFF
Ratio Therapeutics Secures $50M Series B To Develop Cancer …
6 days from now
Jan 18, 2024 · Boston-based pharmaceutical company Ratio Therapeutics has announced the completion of a $50 million Series B financing round to advance its targeted radiotherapies for …
builtinboston.com
OFF
Ratio Therapeutics Raises $50M In Series B Financing
6 days from now
Jan 17, 2024 · In July 2023, Ratio began studying its FAP-targeted, Cu-64-labeled radiopharmaceutical, RTX-1363S, in a Phase I trial in healthy volunteers. According to a …
precisionmedicineonline.com
OFF
Ratio Therapeutics Secures Funds For Cancer Radiotherapies
6 days from now
Jan 18, 2024 · Ratio Therapeutics has secured $50m in a Series B financing round, a significant move aimed at advancing targeted radiotherapies for cancer treatment. The funding, which …
pharmaceutical-technology.com
OFF
Ratio Raises Series B To Advance Radiotherapeutic Into Clinic
6 days from now
Jan 19, 2024 · Ratio Therapeutics Inc. has closed a $50 million series B financing to expand application of its proprietary technology platforms, Trillium and Macropa, to develop novel best …
bioworld.com
OFF
Endpoints News — Jaguar Gene Therapy Spins Out AAV …
6 days from now
Jan 17, 2024 · Ratio raises $50M as radiopharma field finds its groove : 6. news briefing ... Lis said that the Series A raise should get the company through 2025. By then, the biotech aims …
endpts.com
OFF
Ratio Raises $20m To Build On Its Radiopharma Ambitions
6 days from now
2 days ago · Boston-based biotech Ratio Therapeutics has doubled its funding at a stroke with a $20 million Series A that will be used to usher its targeted radiotherapies into clinical testing.
pharmaphorum.com
OFF
Bioscience Equity Partners On LinkedIn: Ratio Raises $50M As ...
6 days from now
Ratio raises $50M as radiopharma field finds its groove https://endpts.com
linkedin.com
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
